You can buy or sell Neurotrope and other stocks, options, ETFs, and crypto commission-free!
Neurotrope, Inc. Common Stock, also called Neurotrope, is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. Read More The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. The listed name for NTRP is Neurotrope, Inc. Common Stock.
New York, New York
52 Week High
52 Week Low